GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » PensionAndRetirementBenefit

Progen Co (XKRX:296160) PensionAndRetirementBenefit : ₩688.7 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co PensionAndRetirementBenefit?

Progen Co's PensionAndRetirementBenefit for the quarter that ended in Dec. 2024 was ₩688.7 Mil.

Progen Co's quarterly PensionAndRetirementBenefit increased from . 20 (₩0.0 Mil) to Dec. 2023 (₩808.2 Mil) but then declined from Dec. 2023 (₩808.2 Mil) to Dec. 2024 (₩688.7 Mil).

Progen Co's annual PensionAndRetirementBenefit increased from . 20 (₩0.0 Mil) to Dec. 2023 (₩808.2 Mil) but then declined from Dec. 2023 (₩808.2 Mil) to Dec. 2024 (₩688.7 Mil).


Progen Co PensionAndRetirementBenefit Historical Data

The historical data trend for Progen Co's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co PensionAndRetirementBenefit Chart

Progen Co Annual Data
Trend Dec23 Dec24
PensionAndRetirementBenefit
808.18 688.73

Progen Co Semi-Annual Data
Dec23 Dec24
PensionAndRetirementBenefit 808.18 688.73

Progen Co PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Progen Co Business Description

Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines